Your logo

Prostate News Archive


  • New prostate probe does it all in 1 shot (St. Louis Post-Dispatch)

    A local company has developed a scanning system that allows physicians to more accurately detect and treat prostate cancer, a leading cause of death among men.

  • Prostate cancer drugs linked to heart disease, diabetes (Lexington Herald-Leader)

    Drugs commonly used to treat prostate cancer might increase the risk of heart disease and diabetes, indicating the treatments should be used more judiciously, researchers reported Monday.

  • Early detection is key in surviving prostate cancer (Point Pleasant Register)

    POINT PLEASANT - There will be approximately 235,000 new cases of it diagnosed in the United States this year. And while one man in every six will get prostate cancer during his lifetime, only one in 34 will die of the disease, with the survival rate increasing each year.

  • Prostate cancer survivor pushes early screenings (Herald & Review)

    DECATUR - Bob Jelks knows firsthand about the importance of preventative screenings and early diagnosis. The nine-year prostate cancer survivor caught the cancer in the early stage during a routine checkup.

  • Prostate cancer talk planned (Billings Gazette)

    Dr. Brad Anderson, urologist, and Dr. John Terry, radiation oncologist, will talk about "Prostate Seed Implants as a Treatment Option for Prostate Cancer" at the Thursday meeting of the Man-to-Man and Side-By-Side groups.

  • Positive clinical results for Active Biotech's prostate cancer project TASQ (SYS-CON Media)

    Active Biotech (ACTI.ST). An interim analysis of the ongoing TASQ Phase I study shows a treatment effect for all evaluated prostate cancer patients. Phase II/III studies are planned to start in year 2007.

  • Back to Prostate News Archive